research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-10-17. Numbers and descriptions here follow the published literature rather than marketing material.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule nuclear receptor ligand |
| Appearance | Off-white to pale yellow solid | Typical for research-grade powder |
| Solubility class | Soluble in DMSO; low water solubility | Common stock solutions use organic solvent |
| Typical stock solvent | Dimethyl sulfoxide | Used for laboratory assays |
| Common analytical method | HPLC with UV or mass detection | Used for identity and purity checks |
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
==== Natural gas ==== Commonly, HIC of natural gas from the same well has a trend of δDmethane < δDethane < δDpropane < δDC4+. This is because most natural gas is thought to be generated by stepwise thermal cracking that is mostly irreversible and thus governed by normal kinetic isotope effects (KIE) that favor light isotopes. The same trend, known as "the normal order", holds for carbon isotopes in natural gas. For example, Angola gas reportedly has a methane δD range of −190‰ to −140‰, an ethane δD of −146‰ to −107‰, a propane δD of −116‰ to −90‰, and a butane δD of −118‰ to −85‰. However, some recent studies show that opposite patterns could also exist, meaning δDmethane > δDethane > δDpropane. This phenomenon is often called 'isotopic reversal' or 'isotopic rollover'. The isotopic order could also be partly reversed, like δDmethane > δDethane < δDpropane or δDmethane < δDethane > δDpropane. Burruss et al. found that in the deepest samples of northern Appalachian basin the hydrogen isotopic order for methane and ethane is reversed. Liu et al., also found partial reversal in oil-related gas from the Tarim Basin. The mechanism causing this reversal is still unknown. Possible explanations include mixing between gases of different maturities and sources, oxidation of methane, etc. Jon Telling et al., synthesized isotopically reversed (in both C and H) low-molecular alkanes using gas-phase radical recombination reactions in electrical discharge experiments, providing another possible mechanism. Methane is the main component of natural gas.
An internal process of natural selection occurs within the body and eventually mutations accumulate within cells to promote their own growth, creating a cancerous tumor that grows and invades various tissues of the body. Normally, a cell divides only in response to signals called growth factors and stops growing once in contact with surrounding cells and in response to growth-inhibitory signals. It usually then divides a limited number of times and dies, staying within the epithelium where it is unable to migrate to other organs. To become a cancer cell, a cell has to accumulate mutations in a number of genes (three to seven). A cancer cell can divide without growth factor and ignores inhibitory signals. Also, it is immortal and can grow indefinitely, even after it makes contact with neighboring cells. It may escape from the epithelium and ultimately from the primary tumor. Then, the escaped cell can cross the endothelium of a blood vessel and get transported by the bloodstream to colonize a new organ, forming deadly metastasis. Although there are some genetic predispositions in a small fraction of cancers, the major fraction is due to a set of new genetic mutations that originally appear and accumulate in one or a small number of cells that will divide to form the tumor and are not transmitted to the progeny (somatic mutations). The most frequent mutations are a loss of function of p53 protein, a tumor suppressor, or in the p53 pathway, and gain of function mutations in the Ras proteins, or in other oncogenes.
The oil industry remained largely state-owned, with the wholly state-owned National Oil Corporation retaining a 70% share in Libya's oil industry, the government also imposed a 93% tax on all oil that foreign companies produced in Libya. Price controls and subsidies over oil and food remained in place, and state-provided benefits such as free education, universal healthcare, free housing, free water and free electricity remained in place. Libya also changed its stance on the WTO after the removal of technocrat Shukri Ghanem, with Gaddafi condemning the WTO as a neocolonial terrorist organisation, and urging African and Third World countries not to join it. While there was no accompanying political liberalization, with Gaddafi retaining predominant control, in March 2010, the government devolved further powers to the municipal councils. Rising numbers of reformist technocrats attained positions in the country's governance; best known was Gaddafi's son and heir apparent Saif al-Islam Gaddafi, who was openly critical of Libya's human rights record. He led a group who proposed the drafting of a new constitution, although it was never adopted. Involved in encouraging tourism, Saif founded several privately run media channels in 2008, but after criticizing the government, they were nationalized in 2009.
=== La–Lem === Marc Lacroix (b. 1963). Belgian biochemist at the Institut Jules Bordet (Brussels), who specializes in breast cancer biology, metastasis and therapy. Keith Laidler (1916–2003). British-Canadian chemist and biochemist at the University of Ottawa. Expert on chemical and enzyme kinetics. Fellow of the Royal Society of Canada. Henry Lardy (1917–2010). American biochemist at the University of Wisconsin, noted for work on metabolism. Member Natl. Acad. Sci. USA. Michel Lazdunski (b. 1938). French biochemist and neuroscientist at Sophia Antipolis. Known especially for work on ion channels. Full Member of the French Academy of Sciences. Jack Legge (1917–1996). Australian biochemist known for his work on blood pigment metabolism and participation in mustard gas trials on Australian Defence Force volunteers during WW2. Albert L. Lehninger (1917–1986). American biochemist at the University of Wisconsin. He discovered, with Eugene P. Kennedy, that mitochondria are the site of oxidative phosphorylation in eukaryotes. Author of several influential texts, including The Mitochondrion, Bioenergetics and Biochemistry. Member Natl. Acad. Sci. USA. Luis Federico Leloir FRS (foreign associate) (1906–1987). Argentinian biochemist at the Fundación Instituto Campomar (Buenos Aires) who worked on sugar nucleotides, carbohydrate metabolism, and renal hypertension. Nobel Prize for Chemistry (1970). Rudi Lemberg FRS (1896–1975). German-Australian biochemist, director of the Kolling Institute of Medical Research from 1935 to 1972. Known for porphyrin research.
Sources: en.wikipedia.org
There was a history and belief in England that the foreign manager could not be successful. Now you have a different feeling, now you think only foreign managers can be successful. That is wrong as well. I believe I contributed to the change in attitude about foreign managers. That can look pretentious but I don't think it is at all. I can show some articles where people tried to prove that the foreign managers can never win an English championship. That has changed and I have certainly contributed to that. But I am also one of the few who also defends English managers.
===== Pakistan ===== During the Cold War and the War in Afghanistan, the US relied on Pakistan to intervene in Afghanistan, and the US military aid to Pakistan at this time caused India's dissatisfaction. In 2009, Robert Blake, Assistant Secretary of State for South and Central Asian Affairs, dismissed any concerns over a rift with India regarding American Af-Pak policy. Calling India and the United States "natural allies", Blake said that the United States cannot afford to meet the strategic priorities in Pakistan and Afghanistan at "the expense of India". From the mid-2000s to 2025, India halved its arms imports from Russia, and has pivoted to buying more from the United States and France. At the same time, Pakistan has doubled its arm imports from China, resulting in a realignment of ties.
==== Homicides ==== On December 28, 2021, 19-year-old Peyton Moyer fatally shot his mother and her boyfriend in Watkinsville, Georgia, while under the influence of the long-acting injectable paliperidone palmitate (Invega Sustenna). On November 2, 2023, Moyer was sentenced to life in prison.
This is a list of investigational headache and migraine drugs, or drugs that are currently under development for clinical use in the treatment of headaches and/or migraines but are not yet approved. They may also be referred to as investigational antimigraine agents. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses. The format of list items is "Name (Synonyms) – Mechanism of Action – Indication [Reference]". This list was last comprehensively updated in September 2025. It is likely to become outdated with time.
==== By phosphate ==== In cyanobacteria, inorganic phosphate (Pi) also participates in the co-ordinated regulation of photosynthesis: Pi binds to the RuBisCO active site and to another site on the large chain where it can influence transitions between activated and less active conformations of the enzyme. In this way, activation of bacterial RuBisCO might be particularly sensitive to Pi levels, which might cause it to act in a similar way to how RuBisCO activase functions in higher plants.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.
It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.
No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.